These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11997270)

  • 1. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein.
    Herrington DM; Howard TD; Brosnihan KB; McDonnell DP; Li X; Hawkins GA; Reboussin DM; Xu J; Zheng SL; Meyers DA; Bleecker ER
    Circulation; 2002 Apr; 105(16):1879-82. PubMed ID: 11997270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
    Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
    Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease.
    Herrington DM; Howard TD; Hawkins GA; Reboussin DM; Xu J; Zheng SL; Brosnihan KB; Meyers DA; Bleecker ER
    N Engl J Med; 2002 Mar; 346(13):967-74. PubMed ID: 11919305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
    Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy.
    Nogueira-de-Souza NC; Guerreiro da Silva ID; Carvalho CV; Pulchinelli A; Haidar MA; Baracat EC; Massad-Costa AM
    Braz J Med Biol Res; 2009 Dec; 42(12):1138-42. PubMed ID: 19936541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.
    Cushman M; Legault C; Barrett-Connor E; Stefanick ML; Kessler C; Judd HL; Sakkinen PA; Tracy RP
    Circulation; 1999 Aug; 100(7):717-22. PubMed ID: 10449693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ER-alpha variants and the cardiovascular effects of hormone replacement therapy.
    Herrington DM; Howard TD
    Pharmacogenomics; 2003 May; 4(3):269-77. PubMed ID: 12718718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
    Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
    Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
    Skouby SO; Gram J; Andersen LF; Sidelmann J; Petersen KR; Jespersen J
    Am J Obstet Gynecol; 2002 May; 186(5):969-77. PubMed ID: 12015523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
    Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women.
    Ylikorkala O; Eviö S; Välimäki M; Tiitinen A
    Fertil Steril; 2003 Sep; 80(3):541-5. PubMed ID: 12969695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen receptor β A1730G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy.
    Darabi M; Ani M; Panjehpour M; Rabbani M; Movahedian A; Zarean E
    Genet Test Mol Biomarkers; 2011; 15(1-2):11-5. PubMed ID: 21117950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women.
    Farzati A; Esposito K; Colacurci N; Fornaro F; Chiantera V; Farzati B
    Fertil Steril; 2002 Mar; 77(3):476-80. PubMed ID: 11872198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
    D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
    Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
    Reuben DB; Palla SL; Hu P; Reboussin BA; Crandall C; Herrington DM; Barrett-Connor E; Greendale GA
    Am J Med; 2006 Feb; 119(2):167.e1-8. PubMed ID: 16443423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.